ing chronic disease or long-term intake of medication interfering with bone metabolism were excluded from this study. Serum 25 (OH) D concentration was measured by licit chromatographic HPLC method (HP Agilent 1200 series, chrom systems kit, Germany), HP A silent technologies 1200 series. Plasma PTH was measured by a chemiluminescent immunoassay (Immulite 2000, Siemens USA). Ca, P, ALP were measured end point read system with colorimetric spectrofotometric method (Roche Hitachi modular Analytics system, Germany)
RESULTS
The mean age of patients during diagnosis was 2.6 years (the smallest child was 6 months and the oldest child was 5 years old). Excluding one child (87.5%) all patients were male. Two of the cases were siblings. They referred to our clinic at autumn and winter seasons. Mean laboratory values during application were as the following: Ca 7.5±1.5 mg/dl, phosphor 4±1.2 mg/dl, ALP 1679±641 U/L and PTH 524±498 pg/ml, excluding two patient whom were within the normal limits, calcium levels were low. Serum P was found low in another three patients and a regular phosphor replacement was needed in one of the cases. (Table 1 ). There was widening at the wrists of all of patients, and rachitic rosary, bell-shaped chest, muscle weakness, hypotonia in 5 cases (Figure 1) . Expansion of the metaphysis, irregularity of the metaphyseal margin, a brush−like appearance, cupping and general osteopenia which typical radiological findings were
INTRODUCTION
Vitamin D also is formed in the skin as a result of direct exposure to sunlight. The liver and kidneys convert vitamin D from food sources or sunlight to an active form called calcitriol. This vitamin has an important role in bone mineral homeostasis by promoting the transport of calcium and phosphate to ensure that the blood levels of these ions are sufficient for the normal mineralization of type I collagen matrix in the skeleton (1) . Vitamin D deficiency results in rickets this situation is common in areas where reception is inadequate (2,3).
Vitamin D was discovered during the 20th century and since vitamin D3 was found to be endogenously produced by the body or that it could be obtained from nutrients, it was immediately used in the treatment of nutritional rickets. However in some cases a resistance was observed against pharmacological doses of Vitamin D and these cases were then classified as vitamin D resistant rickets (VDRR). In further studies, it was stated that rickets resistive against Vitamin D would source from hypophosphatemic rickets, calcium (Ca) intake deficiency or congenital Vitamin D metabolism disorders whereas a resistance against Vitamin D receptor is likely to exist (4, 5) . In contrast to classic vitamin D-deficiency rickets, a number of vitamin D-resistant rachitic syndromes are caused by acquired and hereditary defects in the metabolic activation of the vitamin to its hormonal form, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), or in the subsequent functions of the hormone in target cells (1) .
Clinical and laboratory characteristics of VDRR cases encountered a period of three years are represented here.
MATERIAL AND METHODS
Eight patients who were diagnosed with VDRR during their referral to our pediatric endocrinology outpatient clinic between September 2003 and November 2006 were studied as retrospective. Data related with age, gender and biochemical values of patients were obtained from their files. Therapies which were provided during referrals and clinical follow-ups were carefully scrutinized. Absolute clinical and biochemical improvement periods and the therapeutically dosage during the mentioned periods were recorded. The patients with nutritional rickets due to insufficient nutrition and secondary rickets emerg- 
Figure 2. Radiological appearance of cupping and irregularity of the metaphyseal margin in hand wrist.
eral osteopenia in one case with severe rickets ( Figure  3 ). There was no celiac disease, cystic fibrosis and other chronic disease that effected bone structure in any of our patients. A mean dose of 1.2 µg/kg/day (min.0.5 µg/day, max.2 µg/day) calcitriol was administered to patients. Cases were followed for a mean period of 18 months (average 12-36 months). Serum ALP and PTH values of patients during the follow-up term achieved normal values within a mean period equal to 13.5 months. regulation of physiologic events such as calcium homeostasis and cellular differentiation and proliferation (10) .
Thanks to the effect of ultraviolet rays vitamin D 3 is synthesized in the skin or it can be easily obtained from especially fatty fishes. Risk factors related with Vitamin D deficiency are lack of Vitamin D replacement, premature state, low sunshine exposure, dermal pigmentation and malabsorption (4, 5) . The medical history of our nursing infants demonstrated restricted exposure to sun rays. These patients referred to our clinic during the autumn and winter seasons. None of the patients showed a history of Vitamin D supplementation. Although cholecalciferol given in adequate doses and duration for active rickets, it was not seen the clinical and biochemical improvement in patient presented here. So we thought might vitamin D dependent rickets, and we examined for differential diagnose. Some of our patients (5 cases) who at their suckling period displayed widening at their hand and foot wrists and rachitic rosary were also present. Radiological studies revealed irregularity on metaphies of long bones compatible to active rickets in hand wrist graphs of patients and calyx formation in various levels. There were multiple old fractions on his upper and lower limbs in two patients and there is uncleavaged fracture at her left wrist in ten month years-old girl. Older patients had complaints related with subjective joint and bone pain and were suffering from fatigue.
Vitamin D-dependent rickets type 1A is due to an enzymatic defect in synthesis of the active form of vitamin D caused by mutation in the CYP27B1 gene. VDDR1B is a form of rickets due to mutation in the gene encoding a vitamin D The earliest symptom among our patients was seen when the patients were 6 months old. One of our patients responded well after the dosage of calcitriol was increased to 2 µg /day while all of our patients succeed to respond to calcitriol therapy. Serum P was found low in another two patients and a regular phosphor replacement was needed later three months of initial calcitriol therapy in one of the cases whose respond of therapy was late for a year. However, we were not able to study 1.25(OH) 2 D levels in three patients, and therefore we failed to determine a definite type of rickets for them. Nevertheless, cases can be accepted as non-nutritional rickets patients because their values of 25 (OH) D are normal, and possibly not as type II VDRR; therefore patients can be considered as type I cases as they responded to therapy well in therapeutic doses, perhaps the degree of resistance was fairly low.
Consequently, in rickets cases with persistent increased serum ALP and PTH levels it will be appropriate to investigate serum 25 (OH) D levels in cases diagnosed with VDRR even though hypocalcaemia is absent. Administration of adequate doses of calcitriol in such cases shall allow clinical and laboratory values return to normal.
